CN107132285A - A kind of detection method of the Chinese medicine composition for the treatment of cancer - Google Patents
A kind of detection method of the Chinese medicine composition for the treatment of cancer Download PDFInfo
- Publication number
- CN107132285A CN107132285A CN201710302545.1A CN201710302545A CN107132285A CN 107132285 A CN107132285 A CN 107132285A CN 201710302545 A CN201710302545 A CN 201710302545A CN 107132285 A CN107132285 A CN 107132285A
- Authority
- CN
- China
- Prior art keywords
- prepared
- detection method
- methanol
- reference substance
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Insects & Arthropods (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a kind of detection method of the Chinese medicine composition for the treatment of cancer, the traditional Chinese medicinal composition raw materials composition includes the taste Chinese medicine of motherwort, safflower, Chinese prickly ash, leech etc. 34.Detection method includes:Chromatographic condition:Using methanol-water as mobile phase, isocratic elution, the 320nm of Detection wavelength 250;It is prepared by reference substance solution:Eugenol reference substance is taken to be prepared into reference substance solution;It is prepared by need testing solution:Chinese medicine composition is taken, need testing solution is prepared into after being extracted with organic solvent.The inventive method specificity is strong, and precision, stability, repeatability are good.
Description
It is on October 29th, 2013, Application No. 201310520036.8, entitled " one kind the applying date that the application, which is,
The divisional application of the application for a patent for invention of the detection method of the Chinese medicine composition for the treatment of cancer ".
Technical field
The present invention relates to a kind of detection method of Chinese medicine composition, and in particular to a kind of HPLC detection sides of Chinese medicine composition
Method, belongs to technical field of Chinese medicine.
Background technology
Eugenol, molecular formula is C10H12O2, colourless or pale yellow liquid has strong cloves fragrance, water insoluble.Pharmacology
Research shows that eugenol has inhibitory action in 1: 8000~1: 16000 concentration to pathogenic fungus;1: 2000~1:
During 8000 concentration, there is suppression to make the bacillus such as staphylococcus aureus and pneumonia, dysentery (will is congratulated low), large intestine, deformation, tuberculosis
With;Rabbit vein injection can produce anesthesia, reduce blood pressure, respiration inhibition is acted on anticonvulsion etc.;Show through muscle specimen experiment
There is strong antihistaminicum effect.In addition eugenol can also be used for perfume fragrance and various cosmetic essences and fragrance for detergents formula
In, it can be also used for the allotment of flavoring essence.
Prior art to using HPLC methods the assay of eugenol more, the progress by mobile phase of the acid solution of organic solvent
Elution, such as multitude meets [right《Chinese Pharmacopoeia》The discussion of eugenol content assaying method, new Chinese medicine in version cloves medicinal material in 2010
With clinical pharmacology, 2012,23 (5):579-582] with the acetic acid of methanol -1% water (55: 45) be mobile phase to cloves in cloves medicinal material
The content assaying method of phenol is improved.
The present invention provides a kind of content assaying method of eugenol in Chinese medicine composition of the treating cancer of specific composition, existing
There is technology to have no report to this.
The content of the invention
It is an object of the invention to provide a kind of detection method of the Chinese medicine composition for the treatment of cancer.
The purpose of the present invention is achieved by the following technical solution:
A kind of detection method of the Chinese medicine composition for the treatment of cancer, this method includes:
Chromatographic condition:Using methanol-water as mobile phase, isocratic elution, Detection wavelength 250-320nm;
It is prepared by reference substance solution:Eugenol reference substance is taken to be prepared into reference substance solution;
It is prepared by need testing solution:Chinese medicine composition is taken, need testing solution is prepared into after being extracted with organic solvent;
Determine:Reference substance and need testing solution is taken to be injected separately into liquid chromatograph, according to high effective liquid chromatography for measuring.
Further, the mobile phase volume percentage is methanol: water=(50: 50)~(70: 30);Further, methanol:
Water=(55: 55)~(65: 45);Further, methanol: water=60: 40.
Further, during prepared by reference substance solution, reference substance solution concentration is per 1ml reference substance solutions 20-80 containing eugenol μ
g;Further, reference substance solution concentration is per the 1ml μ of 40-60 containing eugenol g;
Further, during prepared by need testing solution, the organic solvent is dichloromethane, chloroform, ethyl acetate, third
The mixing that any one or a few in ketone, ether, n-butanol, methanol, 50% methanol aqueous solution, ethanol, Diluted Alcohol solution is constituted
Solvent;Further, the organic solvent is methanol;Further, need testing solution concentration is suitable per 1ml need testing solutions
In crude drug 0.01-0.1g;Further, need testing solution concentration is equivalent to crude drug 0.04g per 1ml.
Traditional Chinese medicinal composition raw materials of the present invention are constituted:
Further, the bulk drug composition of the Chinese medicine composition is:
Wherein, the Chinese prickly ash is that charcoal Chinese prickly ash, leech are that leech processed, Rhizoma Sparganii are that vinegar prepared RHIZOMA SPARGANII with vine-gar, rhizoma cyperi are vinegar prepared RHIZOMA CYPERI, myrrh
Processed for vinegar, semen armeniacae amarae is that to fry semen armeniacae amarae, fennel seeds be that salt fennel(parched), excrementum pteropi are that to process excrementum pteropi, corydalis tuber be that vinegar is processed and prolonged to vinegar
Hu Suo, cattail pollen be cattail pollen charcoal, frankincense be vinegar process, dried lacquer be forge dried lacquer, evodia rutaecarpa be liquorice beverage process evodia rutaecarpa, folium artemisiae argyi is processs Chinese mugwort
Leaf.
" Chinese medicine composition " can be the composition that each bulk drug is obtained after crushed described in detection method, also may be used
To be the extract obtained after each bulk drug is extracted through conventional method, can also be each bulk drug extracted through conventional method after again by
The composite preparation that conventional formulation technique is prepared from, such as oral liquid, tablet, capsule, granule.
After the invention described above traditional Chinese medicinal composition raw materials are extracted, add following auxiliary materials and be prepared into oral liquid;The auxiliary material
Including:Flavouring, sweetener, stabilization agent, thickener, dissolving adjuvant, pH adjusting agent, colouring agent, essence;The flavouring
One or more in following:PVP, menthol, dipotassium glycyrrhizinate, malic acid, natrium malicum, tartaric acid, amber
Acid, sodium succinate, acetic acid, glutamic acid, citric acid, sodium citrate, glucolactone, sodium chloride.The sweetener is selected from down
One or more in stating:Sucrose, fructose, glucose, lactose, D-sorbite, maltitol, erythrose, Sucralose, honeybee
Honey, saccharin, steviol glycoside extract, Abbas's sweet tea, acesulfame potassium, sweet protein, radix glycyrrhizae, honey element.Stabilizer may be selected from as follows
It is one or more of:PVP, glycerine, arabo-ascorbic acid and its salt, edetic acid(EDTA), metaphosphoric acid etc..Thickener may be selected from following one kind
Or it is several:Sodium carboxymethylcellulose, agar, PVP, polyvinyl alcohol, xanthans.Dissolving adjuvant may be selected from it is following a kind of or
It is several:Polysorbate, polyethylene glycol, polyoxyethylene hardened castor oil, PVP, sodium hydroxide, polyoxyethylene sorbitan monoleate.PH is adjusted
Agent is selected from following one or more of:Citric acid, sodium citrate, lactic acid, sodium hydroxide, hydrochloric acid, malic acid, natrium malicum, winestone
Acid, butanedioic acid, acetic acid, gluconic acid, phosphoric acid etc..The auxiliary material of oral liquid is most preferably:1-5 parts by weight polyoxyethylene sorbitan monoleate, 1-5 weights
Measure part honey element.
The oral liquor of the Chinese medicine composition comprises the following steps:
Step 1:Turtle shell is added water to cook 2-4 times, each 2-4 hours, merges extract solution, and filtration, filtrate concentration is decocted for turtle shell
Liquid;
Step 2:Radix Angelicae Sinensis, Ligusticum wallichii, turmeric, galangal, Chinese cassia tree, cloves, asafoetide, dalbergia wood steam distillation are extracted 5-7 hours,
Volatile oil and distillate are collected,
Step 3:Step 2 steam distillation is extracted the remaining dregs of a decoction and added water to cook 2-4 times with remaining crude drug, each 1-3
Hour, collecting decoction, filtration, filtrate is concentrated into clear cream 1,
Step 4:The clear cream 1 plus ethanol of step 3 to alcohol content reach 60-80%, and regulation pH value is 7.5~8.0, is stood, filter
Cross, filtrate recycling ethanol, add water to obtain clear cream 2,
Step 5:The turtle shell decocting liquid of the step 1 of clear cream 2 in step 4, boils, lets cool, plus step 2 volatile oil and distillate
And the customary adjuvant of oral liquid, add water and be stirred to dissolve, stand, oral liquid is made through common process in filtration, filtrate;
The step 2 and/or 4 standing are:0~5 DEG C of standing;
The auxiliary material of addition oral liquid is in the step 5:1-5 parts by weight polyoxyethylene sorbitan monoleate, 1-5 parts by weight honey elements.
Brief description of the drawings
Fig. 1 eugenol contrast solution chromatograms
Fig. 2 need testing solution chromatograms
Fig. 3 negative control solution chromatograms
Fig. 4 mobile phases investigate experimental result, and chromatographic peak A is eugenol chromatographic peak
A, the chromatogram of mobile phase 1;B, the chromatogram of mobile phase 2;C, the chromatogram of mobile phase 3;D, the chromatogram of mobile phase 4.
Fig. 5 Extraction solvents investigate experimental result, and chromatographic peak A is eugenol chromatographic peak
A, using methanol as the HPLC chromatogram of Extraction solvent;B, using 50% methanol aqueous solution as the HPLC chromatogram of Extraction solvent
Figure;C, using ethanol as the HPLC chromatogram of Extraction solvent;D, using Diluted Alcohol solution as the HPLC chromatogram of Extraction solvent.
Experimental example 1
1 instrument and reagent
1.1 instrument:SSI1500 high performance liquid chromatographs (UVIS1000 detectors, CSchromPlus chromatographies system
System);The a ten thousandth electronic balances of Sai Duolisi CPA225D ten, Water purifirer ultrapure water machines, TU-1810 UV, visible lights
Spectrophotometer.
1.2 reagent:Methanol is chromatographically pure, and remaining reagent is that analysis is pure, and water is ultra-pure water.
1.3 reference substance:Eugenol provides (lot number by Nat'l Pharmaceutical & Biological Products Control Institute:110725-201112, for containing
Measure fixed use).
1.4 sample:Embodiment 1 prepares oral liquid, lot number 130801,130802,130803, by the Chengdu Di Ao groups self-sufficient and strategically located region
Medicine company limited company provides.
2 methods and result
2.1 method
2.1.1 chromatographic condition and system suitability test
Chromatographic column:Diamonsil-C18 (5 μm, 250 × 4.6mm);
Mobile phase:Methanol-water (60: 40) isocratic elution;
Detection wavelength:280nm;
Flow velocity:1.0ml·min-1;
Column temperature:Room temperature;
2.1.2 prepared by reference substance solution:Precision weighs eugenol reference substance 50.46mg, puts in 100ml measuring bottles, plus methanol
Scale is diluted to, is shaken up, precision measures 10ml, is put in 100ml measuring bottles, plus methanol is to scale, shakes up, and produces (50.46 μ g
ml-1)。
2.1.3 prepared by need testing solution:Precision measures sample 1ml, puts in 25ml volumetric flasks, plus methanol is to scale, shakes up,
Filtration, takes subsequent filtrate, produces.
2.1.4 prepared by negative control solution:The negative sample of scarce eugenol is taken, is prepared by 2.1.3 lower need testing solutions
Method prepares negative solution.
Under these conditions, other component chromatographic peaks can be kept completely separate in eugenol and sample, eugenol color adjacent thereto
The separating degree of spectral peak meets the requirements, and number of theoretical plate (n) is calculated as more than 3000 by eugenol peak, and tailing factor (T) meets the requirements,
And negative control solution in identical retention time without chromatographic peak.See Fig. 1-3.
2.2 method validation
2.2.1 mobile phase is investigated
Take sample (lot number 130801) by need testing solution is prepared under 2.1.3, eluted respectively with mobile phase 1-4,
As a result Fig. 4 is seen.
Mobile phase 1:The glacial acetic acid solution of methanol -1% (55: 45);
Mobile phase 2:Acetonitrile-water (35: 65);
Mobile phase 3:Methanol-water (60: 40);
Mobile phase 4:Methanol-water (70: 30).
From fig. 4, it can be seen that with methanol-water (60: 40) for mobile phase, the peak area of index components eugenol is maximum, and at this
Under the conditions of in eugenol and sample other component chromatographic peak separating effects it is preferable.
2.2.2 Extraction solvent is investigated
Sample is extracted with methanol, 50% methanol solution, ethanol, four kinds of solvents of Diluted Alcohol solution respectively, extract solution
Dissolved after being evaporated with methanol, be measured by 2.1.1 lower chromatographic conditions, as a result see Fig. 5.
As seen from Figure 5, using methanol as Extraction solvent, the peak area of index components eugenol is maximum, and fourth under this condition
Other component chromatographic peak separating effects are preferable in fragrant phenol and sample.
2.2.3 the range of linearity is investigated
Precision weighs eugenol reference substance 15.21mg, puts in 100ml measuring bottles, plus methanol dissolves and is diluted to scale, shakes
It is even, obtain reference substance solution (0.1581mgml-1).Precision measures above-mentioned solution 1,2,3,4,5,6ml, and 10ml measuring bottles are put respectively
In, plus methanol dilution is to scale, shakes up, the μ l of sample introduction 20, injection liquid chromatograph record chromatogram, determine its peak area respectively,
And using peak area as ordinate, mapped by abscissa of reference substance sample size, standard curve is drawn, and calculate regression equation and be:Y
=792244X+691, r=0.9998.
As a result show, in 0.3162~1.8972 μ g ranges, linear relationship is good, is shown in Table 1.
The linear relationship of table 1 investigates result
Sample size (μ g) | 0.3162 | 0.6324 | 0.9486 | 1.2648 | 1.5810 | 1.8972 |
Peak area | 252298 | 498657 | 756586 | 1008757 | 1234758 | 1513758 |
2.2.4 precision test
Precision draws reference substance solution (50.46 μ gml-1) 20 μ l, repeats sample introduction 5 times, determines eugenol peak area, knot
Fruit is shown in Table 2.
Test result indicates that:The precision of instrument is preferable.
The Precision test result of table 2
2.2.5 replica test
Same batch of six parts of sample (lot number 130801) is taken, by need testing solution is respectively prepared under 2.1.3, by 2.1.1
Lower chromatographic condition determines eugenol content, the results are shown in Table 3.
Test result indicates that:This method repeatability is good.
The replica test of table 3
2.2.6 stability test
Take need testing solution (lot number 130801) respectively at 0,2,4,6,8 hours, the μ l of sample introduction 20, eugenol in determination sample
Peak area, the results are shown in Table 4.
Test result indicates that:Need testing solution is basicly stable in 8 hours.
The stability test of table 4
2.2.7 average recovery is tested
Sample (lot number 130801, content 0.7432mgml-1) about 0.5ml of six points of known contents is taken, precision is measured,
It is accurate respectively to add 0.7388mgml-1Reference substance storing solution 0.5ml, by the preparation method system of 2.1.3 lower need testing solutions
Standby sample-adding reclaims test sample liquid, and sample introduction determines its content under 2.1.1 chromatographic conditions, calculates the rate of recovery, the results are shown in Table 5.
The average recovery result of the test of table 5
Test result indicates that:The average recovery measurement result of six experiments is between 95~105%, and its average value is
99.32%, RSD are 1.80%.
2.2.8 sample is determined
Different sample lots are taken, by preparing need testing solution under 2.1.3 and carry out contents by 2.1.1 lower chromatographic conditions
Determine, the results are shown in Table 6.
The sample size of table 6 determines (n=2)
Lot number | Eugenol content (mgml-1) |
130801 | 0.74 |
120101 | 0.36 |
130101 | 0.54 |
Embodiment
The oral liquid of embodiment 1
Bulk drug is constituted:
Preparation method:
The four traditional Chinese medicine material of the above 30, turtle shell is added water to cook 3 times (plus 9 times of water), 3 hours every time, collecting decoction, is filtered, filter
Liquid is concentrated into (about 180ml) in right amount;Radix Angelicae Sinensis, Ligusticum wallichii, turmeric, galangal, Chinese cassia tree, cloves, asafoetide, dalbergia wood steam distillation are extracted
6 hours (plus 12 times of water), collect volatile oil and distillate is appropriate (about 50ml), and the dregs of a decoction and remaining 25-component add water to cook three
Secondary, 2 hours (adding water 12 times), second and third time each 1.5 hours (adding water respectively 10 times, 8 times), collecting decoction, are filtered for the first time,
Filtrate is concentrated into the clear cream that relative density is 1.15 (50~60 DEG C), plus ethanol makes alcohol content up to 70%, and regulation pH value is 7.5~
8.0, (0~5 DEG C) 24 hours are stood, are filtered, filtrate recycling ethanol, it is the clear of 1.06 (50~60 DEG C) to add water to relative density
Cream, adds turtle shell decocting liquid, boils 20 minutes, lets cool, plus volatile oil and distillate and polyoxyethylene sorbitan monoleate, honey element, adds water and stirs
Mixing makes dissolving, stands (0~5 DEG C) 24~48 hours, filtration, and filtrate adds water to ormal weight (1000ml), embedding, sterilizing (105
DEG C, 60min), produce.Every 10ml.
Detection method:
Chromatographic condition:Using octadecylsilane chemically bonded silica as filler;Using 60: 40 methanol-water as flowing equality
Elution, Detection wavelength 280nm, flow velocity 1.0ml/min, detection temperature is room temperature;
It is prepared by need testing solution:Oral liquid 1ml is taken, is placed in 25ml measuring bottles, plus methanol dilution is to scale, shakes up, with micro-
(0.45 μm) filtration of hole filter membrane, takes subsequent filtrate, produces;
It is prepared by reference substance solution:Precision weighs eugenol reference substance 50.46mg, puts in 100ml measuring bottles, plus methanol dilution is extremely
Scale, shakes up, and precision measures 10ml, puts in 100ml measuring bottles, plus methanol is to scale, shakes up, and produces (50.46 μ gml-1);
Determine:Reference substance and each 20 μ l injections high performance liquid chromatograph of need testing solution are drawn respectively, according to high-efficient liquid phase color
Spectrometry is determined, and is produced.
Embodiment 2
Bulk drug is constituted:
Preparation method:
The taste of the above 34, turtle shell is added water to cook 3 times, and 3 hours every time, collecting decoction, filtration, filtrate was concentrated into right amount;
Radix Angelicae Sinensis, Ligusticum wallichii, turmeric, galangal, Chinese cassia tree, cloves, asafoetide, dalbergia wood steam distillation are extracted 6 hours, collect volatile oil and distillation
Appropriate liquid, the dregs of a decoction and remaining 25-component are added water to cook three times, and 2 hours for the first time, second and third time each 1.5 hours, merges and decocts
Liquid, filtration, filtrate is concentrated into the clear cream of relative density about 1.15 (50~60 DEG C), plus ethanol makes alcohol content up to 70%, adjusts pH
It is worth for 7.5~8.0, stands 24 hours, filtration, filtrate recycling ethanol adds water to the clear of relative density about 1.06 (50~60 DEG C)
Cream, adds turtle shell decocting liquid, boils 20 minutes, lets cool, plus volatile oil and distillate, and granule is made through common process.
Detection method:
Chromatographic condition:Using octadecylsilane chemically bonded silica as filler;Using 65: 35 methanol-water as flowing equality
Elution, Detection wavelength 280nm, flow velocity 1.0ml/min, detection temperature is room temperature;
It is prepared by need testing solution:Granule is taken equivalent to crude drug 2g, plus methanol 20ml ultrasonic extraction 30min, extract solution
Stand, filtering takes subsequent filtrate 1ml to be placed in 25ml measuring bottles, plus methanol dilution is to scale, shakes up, with miillpore filter (0.45 μm)
Filtration, takes subsequent filtrate, produces;
Reference substance solution is prepared and assay method be the same as Example 1.
Claims (10)
1. a kind of detection method of the Chinese medicine composition for the treatment of cancer, it is characterised in that this method includes:
Chromatographic condition:Using methanol-water as mobile phase, isocratic elution, Detection wavelength 250-320nm;
It is prepared by reference substance solution:Eugenol is taken to be prepared into reference substance solution;
It is prepared by need testing solution:Chinese medicine composition is taken, need testing solution is prepared into after being extracted with organic solvent;
Determine:Reference substance and need testing solution is taken to be injected separately into liquid chromatograph, according to high effective liquid chromatography for measuring;
Wherein, the traditional Chinese medicinal composition raw materials composition is:
2. detection method as claimed in claim 1, it is characterised in that the bulk drug of the Chinese medicine composition, which is constituted, is:
3. detection method as claimed in claim 1, it is characterised in that the Chinese prickly ash is that charcoal Chinese prickly ash, leech are leech processed, Rhizoma Sparganii
It is that vinegar prepared RHIZOMA CYPERI, myrrh are that vinegar is processed, semen armeniacae amarae is that to fry semen armeniacae amarae, fennel seeds be salt fennel(parched), five spirits for vinegar prepared RHIZOMA SPARGANII with vine-gar, rhizoma cyperi
Fat is that to process excrementum pteropi, corydalis tuber be that to process corydalis tuber, cattail pollen be that cattail pollen charcoal, frankincense are that vinegar is processed, dried lacquer is forges dried lacquer, evodia rutaecarpa to vinegar to vinegar
Evodia rutaecarpa, the folium artemisiae argyi processed for liquorice beverage are to process folium artemisiae argyi.
4. detection method as claimed in claim 1, it is characterised in that the mobile phase volume percentage is methanol: water=(50
: 50)~(70: 30).
5. detection method as claimed in claim 4, it is characterised in that the mobile phase volume percentage is methanol: water=(55
: 55)~(65: 45).
6. detection method as claimed in claim 5, it is characterised in that the mobile phase volume percentage is methanol: water=60:
40。
7. detection method as claimed in claim 1, it is characterised in that in prepared by reference substance solution, reference substance solution concentration is
Per the 1ml reference substance solutions μ of 20-80 containing eugenol g.
8. detection method as claimed in claim 1, it is characterised in that in prepared by need testing solution, the organic solvent is two
Chloromethanes, chloroform, ethyl acetate, acetone, ether, n-butanol, methanol, 50% methanol aqueous solution, ethanol, Diluted Alcohol solution
In any one or a few constitute mixed solvent.
9. detection method as claimed in claim 8, it is characterised in that in prepared by need testing solution, the organic solvent is first
Alcohol.
10. detection method as claimed in claim 8, it is characterised in that need testing solution concentration is per 1ml need testing solution phases
When in crude drug 0.01-0.1g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710302545.1A CN107132285A (en) | 2013-10-29 | 2013-10-29 | A kind of detection method of the Chinese medicine composition for the treatment of cancer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310520036.8A CN104569169A (en) | 2013-10-29 | 2013-10-29 | Detection method for traditional Chinese medicine for treating cancer |
CN201710302545.1A CN107132285A (en) | 2013-10-29 | 2013-10-29 | A kind of detection method of the Chinese medicine composition for the treatment of cancer |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310520036.8A Division CN104569169A (en) | 2013-10-29 | 2013-10-29 | Detection method for traditional Chinese medicine for treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107132285A true CN107132285A (en) | 2017-09-05 |
Family
ID=53085730
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710302545.1A Pending CN107132285A (en) | 2013-10-29 | 2013-10-29 | A kind of detection method of the Chinese medicine composition for the treatment of cancer |
CN201310520036.8A Pending CN104569169A (en) | 2013-10-29 | 2013-10-29 | Detection method for traditional Chinese medicine for treating cancer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310520036.8A Pending CN104569169A (en) | 2013-10-29 | 2013-10-29 | Detection method for traditional Chinese medicine for treating cancer |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN107132285A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110208400B (en) * | 2019-05-21 | 2023-09-19 | 新疆农业科学院农产品贮藏加工研究所 | Method for determining phenol content of various monomers in red dates |
-
2013
- 2013-10-29 CN CN201710302545.1A patent/CN107132285A/en active Pending
- 2013-10-29 CN CN201310520036.8A patent/CN104569169A/en active Pending
Non-Patent Citations (1)
Title |
---|
严铭铭 等: "小儿温胃颗粒剂中丁香酚HPLC测定", 《中国实验方剂学杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN104569169A (en) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102671140B (en) | Anticancer traditional Chinese medicine combination oral liquid, preparation method and detection method thereof | |
CN101062077B (en) | Method for preparing stevia whole stevioside and stevia whole flavone at the same time | |
US9341605B2 (en) | Chemical profile of detecting bioactive components of quinones, stilbenes, flavones and alkaloids | |
CN102749401B (en) | Inspection method of traditional Chinese medicine composition twenty-five-ingredient lung disease preparation | |
CN102590433A (en) | Ganchang preparation quality detection method | |
CN104758515A (en) | Traditional Chinese medicinal composition for treating nephropathy as well as preparation method and detection method thereof | |
CN103230517B (en) | A kind of decoction made from radix adenophorea, tuber of dwarf lilyturf granule and preparation method thereof and detection method | |
CN101085224A (en) | 'Mailuoning' injection preparation and its quality control method | |
CN110187044A (en) | A kind of quality determining method of Yinqiao Jiedu oral liquid | |
CN101028460B (en) | Method for inspecting throat-clearing Chinese medicinal pills | |
CN102058814B (en) | General flavone extractive of four medicaments including grassleaf sweetflag rhizome and preparation method thereof | |
CN112526014B (en) | Jinyinliang oral liquid fingerprint spectrum and establishing method thereof | |
CN104820029B (en) | Content detection method for compound houttuynia cordata mixture | |
CN100570358C (en) | Treat the detection method of asthenopic pharmaceutical preparation | |
CN103940942B (en) | A kind of detection method of CHANGYANNING preparation | |
CN106918673A (en) | A kind of method for building up of the finger-print of Chinese medicine composition | |
CN107132285A (en) | A kind of detection method of the Chinese medicine composition for the treatment of cancer | |
CN101953978B (en) | Heart-soothing and lipid-lowering tablet medicine quality detecting method | |
CN104274727A (en) | Quality detection method of throat-clearing and construction-nourishing oral liquid | |
CN103923138B (en) | A kind of preparation method of Nicotifiorin and application thereof | |
CN107389827A (en) | The assay method of stachydrine hydrochloride content in motherwort or its compound preparation | |
CN103239506A (en) | Tongmai oral liquid raw material extract | |
CN103123343A (en) | Quality control method for Songling Xuemaikang capsules | |
CN103316087B (en) | Semen Myristicae five tastes effective site and preparation method thereof, quality determining method and application | |
CN103110890A (en) | Effective part of Xierigasiwei (Mongolian medicine) as well as preparation method, quality detection method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170905 |